Glioblastoma is a dangerous brain cancer known for its rapid growth and unresponsiveness to standard treatments. Studies are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is